Advertisement
Advertisement
ZBH
Zimmer Biomet Holdings, Inc.
93.22
USDSponsored
+0.63
+0.68%
Mar 13, 16:00 UTC -4
Closed
After-Market
93.43
+0.21
+0.23%
ZBH Earnings Reports
Positive Surprise Ratio
ZBH beat 28 of 40 last estimates.
70%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.09B
/$1.87
Implied change from Q4 25 (Revenue/ EPS)
-7.06%
/-22.73%
Implied change from Q1 25 (Revenue/ EPS)
+9.23%
/+3.31%
Zimmer Biomet Holdings, Inc. earnings per share and revenue
On Feb 10, 2026, ZBH reported earnings of 2.42 USD per share (EPS) for Q4 25, Inline the estimate of 2.41 USD, resulting in a 0.00% surprise. Revenue reached 2.24 billion, compared to an expected 2.25 billion, with a -0.42% difference. The market reacted with a +1.86% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 24 analysts forecast an EPS of 1.87 USD, with revenue projected to reach 2.09 billion USD, implying an decrease of -22.73% EPS, and decrease of -7.06% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BillionToOne, Inc. Class A Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.08
Actual
$0.11
Surprise
+27.02%
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.14
Surprise
+6.63%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
Myomo Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.08
Surprise
+2.19%
FAQ
What were Zimmer Biomet Holdings, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Zimmer Biomet Holdings, Inc. reported EPS of $2.42, missing estimates by 0%, and revenue of $2.24B, -0.42% below expectations.
How did the market react to Zimmer Biomet Holdings, Inc.'s Q4 2025 earnings?
The stock price moved up 1.86%, changed from $89.73 before the earnings release to $91.40 the day after.
When is Zimmer Biomet Holdings, Inc. expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Zimmer Biomet Holdings, Inc.'s next earnings report?
Based on 24
analysts, Zimmer Biomet Holdings, Inc. is expected to report EPS of $1.87 and revenue of $2.09B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement